GS Medical USA commenced full launch of AnyPlus® Direct Lateral Interbody Fusion (DLIF), as well as Anterior and Posterior Disc Prep Sets.
AnyPlus DLIF was alpha-launched earlier this year, following introduction of the company’s AnyPlus® Anterior Cervical Interbody Fusion and the AnyPlus® Dual-Lead Pedicle Screw systems. Additional products in the launch queue include a Chrome Cobalt Rod for scoliosis; upgrades to the AnyPlus® NX Percutaneous Pedicle Screw, focusing on ease of use; and a standalone interbody system and posterior cervical application. Further, the company will expand distribution partnerships for demineralized bone matrix, allograft and kyphoplasty products.
ORTHOWORLD estimated GS Medical’s 2016 revenue in the range of US $50.0MM to $55.0MM. The company has announced 2Q17 growth of 32% year over year, and expects continued strong momentum from its numerous product launches.
Sources: GS Medical USA; ORTHOWORLD Inc.; ORTHOWORLD estimates
GS Medical USA commenced full launch of AnyPlus® Direct Lateral Interbody Fusion (DLIF), as well as Anterior and Posterior Disc Prep Sets.
AnyPlus DLIF was alpha-launched earlier this year, following introduction of the company's AnyPlus® Anterior Cervical Interbody Fusion and the AnyPlus® Dual-Lead Pedicle Screw systems. Additional products...
GS Medical USA commenced full launch of AnyPlus® Direct Lateral Interbody Fusion (DLIF), as well as Anterior and Posterior Disc Prep Sets.
AnyPlus DLIF was alpha-launched earlier this year, following introduction of the company’s AnyPlus® Anterior Cervical Interbody Fusion and the AnyPlus® Dual-Lead Pedicle Screw systems. Additional products in the launch queue include a Chrome Cobalt Rod for scoliosis; upgrades to the AnyPlus® NX Percutaneous Pedicle Screw, focusing on ease of use; and a standalone interbody system and posterior cervical application. Further, the company will expand distribution partnerships for demineralized bone matrix, allograft and kyphoplasty products.
ORTHOWORLD estimated GS Medical’s 2016 revenue in the range of US $50.0MM to $55.0MM. The company has announced 2Q17 growth of 32% year over year, and expects continued strong momentum from its numerous product launches.
Sources: GS Medical USA; ORTHOWORLD Inc.; ORTHOWORLD estimates
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
